Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Sarepta Therapeutics Inc (NASDAQ:SRPT)

34.10
Delayed Data
As of 4:00pm ET
 +1.44 / +4.41%
Today’s Change
8.00
Today|||52-Week Range
63.73
-11.61%
Year-to-Date
Is This Why Sarepta Therapeutics Fell 14.5% in November?
9:32am / MotleyFool.com - Paid Partner Content
What Happened in Biotech in 2016?
Nov 22 / MotleyFool.com - Paid Partner Content
Healthcare Bill Up for House Vote Wed. Hailed as Game-Changer, Blasted as Pharma Hand...
Nov 29 / TheStreet.com - Paid Partner Content
 

Today’s Trading

Previous close32.66
Today’s open32.86
Day’s range32.39 - 34.19
Volume2,261,251
Average volume (3 months)3,682,637
Market cap$1.8B
Dividend yield--
Data as of 4:00pm ET, 12/05/2016

Growth & Valuation

Earnings growth (last year)-53.39%
Earnings growth (this year)+8.14%
Earnings growth (next 5 years)+0.37%
Revenue growth (last year)-87.16%
P/E ratioNM
Price/Sales1,302.11
Price/Book7.83

Competitors

 Today’s
change
Today’s
% change
SAGESAGE Therapeutics In...+2.80+5.71%
HCMHutchison China Medi...+0.51+3.55%
PRTAProthena Corporation...+0.87+1.61%
CBMCambrex Corp-0.55-1.08%
Data as of 4:02pm ET, 12/05/2016

Financials

Next reporting dateMarch 2, 2017
EPS forecast (this quarter)-$1.12
Annual revenue (last year)$1.3M
Annual profit (last year)-$220.0M
Net profit margin-17,560.26%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive &
Medical Officer
Edward M. Kaye
Head-Operations &
Vice President
Gavin T. Malenfant
Corporate headquarters
Cambridge, Massachusetts

Forecasts


Search for Jobs